User:AYM.NAZIM

Autobiography of Dr. AYM NAZIM (Opu)

"The hidden treasures of science, St. Bonaventure tells us, can be discovered … in a knowledge of either the principles or the conclusions of sciential demonstrations."

- John Francis

I born in 30th March, 1979 on Sylhet.

Empirical activities:

•	I consider myself a hardworking and creative person, with the ability to grasp new concepts quickly.

•	I am energetic and enthusiastic to take on new challenges in life.

•	I wish to utilize my services in institutions and medical services of

•	High international repute where I can better show my skills and indulge in Continued Medical Education.

•	I have strong passion for undergraduate / Postgraduate Medical Teaching & Research in Basic & Applied Medical Sciences especially Pathology.

•	I like to approach patients with compassion and offer them diagnostic as well as therapeutic services for haematological diseases.

•	I am always willing to take up new challenges and adjust myself well to change. I like to look ahead to the future with a bold and positive attitude that I try to infuse in my colleagues too so that we can strive together towards a common goal__ the patients welfare.

•	I would like to enhance my career and professional exposure through Continuing Medical Education (CME).

My deamscape:

~To build my career as a Hematologist with a view to making effective contribution towards management and treatment of the patients suffering from blood disorders specially blood cancer through research and policy interventions.

~To contribute and get myself actively involved in the establishment of Bone Marrow Transplant Center in Bangladesh.

~I am a medical professional who believes in learning the best care in patients management while conducting medical practice in full conformance with principles of the  Declaration of Helsinki , Good clinical Practice (GCP) within laws and regularities of the country of workplace, considering how quality of my patients care has been assumed, keeping in consideration the priority of patient's interest over those of science.

~

To contribute medical knowledge & other significant talents to a public service organization.

To gain experiences in the fields of hematology and wish to contribute my knowledge and efforts in the advancement of hematological research for betterment in patient care.

~To possess such a portfolio of achievements, which is enriched of serving clientele of organization to carry a great weight and have significant effects in life.

Professional Experiences:

~Completed one year Internship training from Jalalabad Ragib Rabeya Medical College under Shahjalal University of Science & Technology (SUST), Sylhet.

Contact: 0088-0821-719090-6, Fax: 0821-719096, Web: www.jrrmc.edu.bd

~Worked as a Lecturer of Pharmacology & Therapeutics in Jalalabad Ragib Rabeya Medical College, Pathantula, Sylhet since 12th July, 2005 to July 2008 (including study leave: from Jan 08 to July 08)

Web: www.jrrmc.edu.bd

~Worked as a Chief Medical Officer in Nurjahan General Hospital, Dargagate, Sylhet from 09-04-2005 to 10-12-2006.

~Occupied as a Medical Officer in the dept. of Cardiology since 2nd August, 2008 to February,2009 in National Heart Foundation & Research Institute, Section-2, Mirpur-1216, Dhaka.

Web: www.nhfbd.org

~Occupied as a Medical Officer in Al-Zahra Renal Transplant Center & General Hospital, Zahra, Libya since April, 2010 to February, 2010.

~Occupied as an Emergency Medical Officer in East West Medical College & Hospital in the year 2012-2013.

( http://eastwestmedicalcollege.com/ )

~Occupied as an Emergency  Medical Officer in Enam Medical College & Hospital in the year 2012-2013. - Since February, 2020 I have been serving as Registrar, Haematology in North East Medical College Hospital, Sylhet - Head of Apheresis Unit, North East Medical College Hospital, Sylhet

( http://emch.com.bd/emch/college/ )

~Completed Special Teaching course on Epilepsy & EEG (Electroencephalogram), organized by Bangladesh Neurology Foundation.

~Participated in Workshop “Assessment of Training Needs of Field Level Medical Practitioners” include “Emergency Preparedness & Response” conducted & financed by WHO.

~Participated in Workshop as a Resource person in Community participation & Management of WSS(28th-31st May,2007) and (5th-8thMay,2008) on “Health Education & Hygiene Promotion” conducted by International Training Network & hosted by Dept. Civil & Environmental Engineering, Shahjalal University of Science & Technology(SUST).

	Participated in Seminar and workshop held on World Heart Day-2008 and World Hypertension Day-2008.

	Participated in National Conference as a Rapporteur on “Management of HF”: Current status, Emerging guidelines & Future trends organized by National Heart Foundation Hospital & Research Institute on 1st & 2nd December,2008.

	Completed Teaching Seminar on Chronic Non-Communicable Disease Epidemiology & Prevention from 16-20th November-, 2008; conducted by WHO.

	Completed Teaching Seminar on Chronic Non-Communicable Disease Epidemiology & Prevention from 17-21th October-, 2008; conducted by WHO.

	 Attended & presented at the 62nd Annual Meeting of the American Society of Human Genetics held at the Moscone Convention Center in San Francisco over the dates of November 6-10, 2012.

	Improving Patient Outcomes in Multiple Sclerosis: Clinical Trial Data and Management Strategies :An interactive CME program provided by Novartis Pharmaceuticals Corporation

Duration: September 26, 2013 to September 25, 2014

Post graduation trainings:

	Completed  post graduation training (6 Months) in Haematology in BSMMU (Bangabandu Sheikh Mujib Medical University) from January,2008 - June, 2008, Web:  www.bsmmu.org

	Completed  post graduation training (1 year) in Cardiology in National Heart Foundation & Research Institute, Section-2, Mirpur-1216, Dhaka. Web: www.nhfbd.org

	Completed  post graduation training (6 Months) in Medicine, Unit-Red in Bangabandu Sheikh Mujib Medical University (BSMMU) from July,2011 - December, 2011, Web: www.bsmmu.org

	Completed  post graduation training (24 Months) in Clinical Haematology and Haematology Laboratory from 1st July, 2012 - 30th June, 2014 in Dept. of Hematology and BMT in Dhaka Medical College & Hospital.

Web: http://www.hematologydmch.com

	Completed post graduation training (6 Months) Dept. of Medicine (Unit-VII) in Dhaka Medical College & Hospital from July2012 - December, 2012.

	Successfully Completed 6 months certificate course on Diabetology from Bangladesh Institute of Diabetes,Endocrine & Metabolic Disorders (BIRDEM).

CME Certificates:

•	Association of Sickle Cell Trait with kidney disease and Albuminuria in African Americans; JAMA.2014;312(20):2115-2125.dio:10.1001/jama2014.15063

•	Chronic Lymphocytic Leukaemia; JAMA.2014;312(21)2265-2276.doi:10.1001/jama2014.14553

•	Renoprotective Effect of Renin-Angiotensin-Aldosterone System Blockade in Patients With Predialysis Advanced Chronic Kidney Disease, Hypertension, and Anemia; JAMA Intern Med.2014;174(3):347-354. doi:10.1001/jamainternmed.2013.12700

•	Challenges in Management of Haemophilia in Children; http://www.medscape.org/viewarticle/842620 ; Presented through a collaboration between the National Hemophilia Foundation and Medscape.

•	Acute Myeloid Leukaemia and Myelodysplastic Syndrome in Older Patients; Certificate no: 54099995; awarded maximum of 2.25 AMA PRA Category 1Credit(S)TM, Medscape LLC, accredited by Accreditation Council for Continuing Medical Education (ACCME)

•	Anticoagulation for VTE: When Is it Safe to Stop? ; Certificate no: 50048698; awarded maximum of 0.50 AMA PRA Category 1 Credit(s)™, Medscape LLC, accredited by Accreditation Council for Continuing Medical Education (ACCME)

•	Current Controversies in Venous Thromboembolism Treatment: Agents, Regimens, and Reversal; Certificate no: 53119257, awarded maximum of 0.50 AMA PRA Category 1 Credit(s)™, Johns Hopkins University School of Medicine

•	Diagnosis and Treatment of High-Risk Chronic Myeloid Leukaemia; Certificate no: 55338291, awarded maximum of 0.50 AMA PRA Category 1 Credit(s)™, Medscape LLC, accredited by Accreditation Council for Continuing Medical Education (ACCME)

•	Emerging Paradigms in Haemophilia; Certificate no: 51524882, awarded maximum of 2.50 AMA PRA Category 1 Credit(s)™, Perelman School of Medicine, University of Pennsylvania, accredited by Accreditation Council for Continuing Medical Education (ACCME)

•	New Treatment Algorithms in Relapsed CLL; Certificate no: 53014996, awarded maximum of 1.75 CPD credit, approved by faculty of pharmaceutical Medicine at WebMD Global

•	PI3K Inhibitors in CLL and NHL: New Challenges in Clinical Practice; Certificate Number: 53048087, awarded maximum of 0.50 CPD credit, approved by faculty of pharmaceutical Medicine at WebMD Global

•	PI3K Inhibitors in CLL and NHL: Where Are We Now? ; Certificate Number: 51394389, awarded maximum of 0.50 CPD credit, approved by faculty of pharmaceutical Medicine at WebMD Global

•	Proteasome Inhibition and Multiple Myeloma: An Update; Certificate no: 55913114, awarded maximum of 2.00 CPD credit, approved by faculty of pharmaceutical Medicine at WebMD Global

•	Removing the Escape Hatch: Restoring Immune System Activation and Memory in Cancer; Certificate Number: 53050420, awarded maximum of 0.50 AMA PRA Category 1 Credit(s)™, Medscape LLC, accredited by Accreditation Council for Continuing Medical Education (ACCME)

•	The Real World of NOACs; Certificate Number: 53050870, awarded maximum of 0.50 AMA PRA Category 1 Credit(s)™, Medscape LLC, accredited by Accreditation Council for Continuing Medical Education (ACCME)

•	Clinical Challenges in HIV Management: A Two Part Educational Series; awarded maximum of 4 AMA PRA Category 1 Credit, Pennstate Hershey, College of Medicine.

•	Clinical Challenges in the Assessment and Management of Hepatitis C: A TwoPart Educational Series; awarded maximum of 4 AMA PRA Category 1 Credit, Pennstate Hershey, College of Medicine.

•	Multiple Myeloma may be driven by CAR cells; awarded maximum of 0.25 AMA PRA Category 1 Credit, Pennstate Hershey, College of Medicine.

•	Mayo Clinic Proceedings: Non-Hodgkin Lymphoma: Diagnosis and Treatment; awarded maximum of 1.00 AMA PRA Category 1 Credits™.

•	Suicidal Ideation Higher For Cancer Survivors: Medpage today, awarded maximum of 0.25 AMA PRA Category 1 Credits™.

•	How to get published: structuring your article; Elsevier Publishing Campus, www. publishingcampus.com

•	How to get published: preparing your manuscript; Elsevier Publishing Campus, www. publishingcampus.com.

•	Strategies for Early Diagnosis and Optimal Treatment of Invasive Fungal Infections, on August 1, 2018 by Boston University School of Medicine, designated for 1.0 AMA PRA Category 1 Credit(s)™.

Hobbies & Interests:

•	I have intense interest in conducting research work on Haematological Cancer with special interest in the recent developments in treating Acute leukaemia patients.

•	I am very much keen to work with team of Bone Marrow transplantation.

•	Reading history, novels, Mythology for pleasure.

•	Astronomy, Traveling & Music, watching movies.

Computer literacy:

•	Excellent command in MS Office (Word, Excel, PowerPoint)

•	Net surfing, IE, Google, Yahoo, Medscape, Pubmed Jounals, NCCN.

•	Acquainted with data entry and analysis by SPSS, Epi info

•	Can conduct scientific seminars, investigators’ meeting and Advisory Board Meeting to complement marketing strategic initiatives of all assigned brands.

•	Able to develop and maintain strong professional relationship with the top KOLs.

•	Can develop and maintain innovative patient centric support program to ensure patient compliance and patient empowerment.

•	Able to monitor ongoing and new clinical studies and timely publish result in the scientific journals.

Language Skill: Written & Verbal fluency in English, Arabic & Verbal frequency in Hindi.

Member of following voluntary & Institutional Organizations:

	  Permanent member of BMA (Bangladesh Medical Association).

	  Lifelong Member of “Shandhani” a Blood donating organization of Bangladesh.

	American Society of Hematology (ASH)

	European Hematology Association (EHA)

	HFA Blood Brotherhood Programme

	Bloodmed.com

	World's Largest Market Research Resource

	Health Prior.com, infocenter@scientology.net

	PRS: Clinical Trial.gov

	American Society of human genetics (ASHG)

	Member of  National center of Biotechnology Information (NCBI)

	Member of  OMIM (Online Mandelian Inheritance of Man)

	Member of WCIM (World congress of Internal Medicine)

	Member of  OMICS group

Publications and clinical trials:

1.	“Drug Use Pattern in Hospital Outpatient and General Practice in Sylhet City”- Jalalabad Medical Journal ISSN 1818-1104, Volume 03, Number 02, July 2006.

2.	Use of Potassium Citrate in Restless Leg Syndrome (RLS)- Jalalabad Medical Journal ISSN 1818-1104, Volume 03, Number 06, July 2007.

3.	A randomized observational study on Clinical profile of Obesity in 100 patients attending in Out Patient Department (OPD) of National Heart Foundation Hospital & Research Institute (NHFH&RI) from August,2008 to February,2009.

4.	A case report on pregnancy with acute promyelocytic leukemia with DIC. (Submitted to OMICS group conference, 2nd International conference on hematology & blood disorders; http://www.omicsgroup.com/hematology-blood-disorders-conference-2014/

5.	A case report on Auto Immune Hemolytic Anaemia in a patient of Acute Myeloid Leukemia. (Submitted for publication to OMICS group conference, 2nd International conference on hematology & blood disorders; http://www.omicsgroup.com/hematology-blood-disorders-conference-2014/ )

6.	Participated as a principal investigator in a study: Tranexamic acid for the treatment of significant traumatic brain injury: an international randomized, double blind placebo controlled trial, Trail acronym: CRASH-3, protocol number: ISCTN15088122,EUDRACT Number:2011-003669-14,Clinical Trial GOV ID: NCT01402882.

7.	A case Report: 3yrs old girl of Congenital dyserythropoietic Anaemia (CDA)

8.	A Case Report: Hereditary Pyropoikilocytosis. (submitted for publication to OMICS group conference, 2nd International conference on hematology & blood disorders; http://www.omicsgroup.com/hematology-blood-disorders-conference-2014/ )

9.	A case report on Coomb’s Negative Evan’s syndrome. (submitted for publication to OMICS group conference, 2nd International conference on hematology & blood disorders; http://www.omicsgroup.com/hematology-blood-disorders-conference-2014/ )

10.	Case report: A young woman of  B-cell ALL with DVT. (submitted for publication to OMICS group conference, 2nd International conference on hematology & blood disorders; http://www.omicsgroup.com/hematology-blood-disorders-conference-2014/ )

11.	A Case report: Blastic crisis of atypical chronic myeloid leukaemia with multiple chloromas in a young boy. (submitted for publication to OMICS group conference, 2nd International conference on hematology & blood disorders; http://www.omicsgroup.com/hematology-blood-disorders-conference-2014/ )

12.	A Case report: A 22yr old lady of CML presented with splenic rupture. (submitted for publication to OMICS group conference, 2nd International conference on hematology & blood disorders; http://www.omicsgroup.com/hematology-blood-disorders-conference-2014/ )

13.	A case report: 13yr old boy of CML presented with bilateral orbital swelling. (submitted for publication to OMICS group conference, 2nd International conference on hematology & blood disorders; http://www.omicsgroup.com/hematology-blood-disorders-conference-2014/ )

14.	Participated as an investigator in cross sectional study done in National Heart Foundation Hospital & Research Institute  entitled  “Lipid profile and tobacco consumption among hypertensive patients attending in NHFH&RI”.

15.	Participated in a cohort study of  sponsored by Sanofi Aventis : Evaluation of clinical effects and tolerability of Cefepime (Winnipime) in Hospital settings, (WIN-HOPE), study number: CEFEPL06578  conducting in department of Haematology, DMCH.

16.	Review article: Zika virus: epidemics and recent threat to Bangladesh, submitted to journal of Sylhet Women’s Medical College.

17.	Worked as principal investigator from Enam Medical College and Hospital ( http://emch.com.bd/emch/college/ ) in CRASH-3 trial : Tranexamic acid for the treatment of significant traumatic brain injury; an international randomized, double blind placebo controlled trial (Started on 1st December, 2011, Protocol no: ISRCTN15088122), CRASH-3 Trial coordinating center: Clinical trial unit, London School of Hygiene and Tropical Medicine, email: crash@lshtm.ac.uk, http://craash3.ishtm.ac.uk

18.	Working as a principal investigator from Dhaka Medical College and Hospital in HALT-IT trial: Tranexamic acid for the treatment of gastrointestinal haemorrhage, an international randomized, double blind placebo controlled trial (Started on 2nd January, 2013, Protocol no: ISRCTN11225767), HALT-IT Trial coordinating center: Clinical trial unit, London School of Hygiene and Tropical Medicine, email: crash@lshtm.ac.uk, http://craash3.ishtm.ac.uk